UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000043917
Receipt number	R000050098
Scientific Title	Observational study investigating the efficacy and safety of fulvestrant + CDK4 / 6 inhibitor as a primary endocrine therapy for hormone receptor-positive, HER2-negative advanced/metastatic breast cancer
Date of disclosure of the study information	2021/04/14
Last modified on	2021/04/14 07:35:40

---